BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 22883171)

  • 1. [Multi-state model in the evaluation of outcome on mild cognitive impairment to Alzheimer's disease].
    Gao JW; Yang SS; Zhou LY; Wang XC; Gao CH; Song PP; Yu HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 May; 33(5):470-3. PubMed ID: 22883171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multi-state Markov model in outcome of mild cognitive impairments among community elderly residents in Mainland China.
    Yu HM; Yang SS; Gao JW; Zhou LY; Liang RF; Qu CY
    Int Psychogeriatr; 2013 May; 25(5):797-804. PubMed ID: 23286508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Competing risk model based study of outcomes of mild cognitive impairment of seniors].
    Sun Q; Song Y; Kong P; Yu H
    Zhonghua Liu Xing Bing Xue Za Zhi; 2015 Mar; 36(3):241-4. PubMed ID: 25975401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors of transition from mild cognitive impairment to Alzheimer's disease and death: A cohort study.
    Xue H; Sun Q; Liu L; Zhou L; Liang R; He R; Yu H
    Compr Psychiatry; 2017 Oct; 78():91-97. PubMed ID: 28806610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Multi-state Markov model in expressing the outcome of mild cognitive impairment among community-based elderly residents].
    Yang SS; Zhou LY; Liang RF; Luo TE; Qu CY; Yu HM
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Jan; 32(1):25-8. PubMed ID: 21518536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A three-year follow-up study on the transfer of mild cognitive impairment to Alzheimer's disease among the elderly in Taiyuan city].
    Wang YP; Zhai JB; Zhu F; Zhang WW; Yang XJ; Qu CY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2011 Feb; 32(2):105-9. PubMed ID: 21518614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Depression in mild cognitive impairment is associated with progression to Alzheimer's disease: a longitudinal study.
    Van der Mussele S; Fransen E; Struyfs H; Luyckx J; Mariën P; Saerens J; Somers N; Goeman J; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2014; 42(4):1239-50. PubMed ID: 25024328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural progression model of cognition and physical functioning among people with mild cognitive impairment and alzheimer's disease.
    Handels RL; Xu W; Rizzuto D; Caracciolo B; Wang R; Winblad B; Verhey FR; Severens JL; Fratiglioni L; Joore MA; Wimo A
    J Alzheimers Dis; 2013; 37(2):357-65. PubMed ID: 23948894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the risk of conversion of mild cognitive impairment of Alzheimer type to Alzheimer's disease in a south Brazilian population-based elderly cohort: the PALA study.
    Godinho C; Camozzato AL; Onyszko D; Chaves ML
    Int Psychogeriatr; 2012 Apr; 24(4):674-81. PubMed ID: 22088617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Injury markers but not amyloid markers are associated with rapid progression from mild cognitive impairment to dementia in Alzheimer's disease.
    van Rossum IA; Visser PJ; Knol DL; van der Flier WM; Teunissen CE; Barkhof F; Blankenstein MA; Scheltens P
    J Alzheimers Dis; 2012; 29(2):319-27. PubMed ID: 22233766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic transitions in mild cognitive impairment subtypes.
    Forlenza OV; Diniz BS; Nunes PV; Memória CM; Yassuda MS; Gattaz WF
    Int Psychogeriatr; 2009 Dec; 21(6):1088-95. PubMed ID: 19691909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalizability of the disease state index prediction model for identifying patients progressing from mild cognitive impairment to Alzheimer's disease.
    Hall A; Muñoz-Ruiz M; Mattila J; Koikkalainen J; Tsolaki M; Mecocci P; Kloszewska I; Vellas B; Lovestone S; Visser PJ; Lötjonen J; Soininen H; ; ;
    J Alzheimers Dis; 2015; 44(1):79-92. PubMed ID: 25201784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Transition Probabilities Across the Alzheimer's Disease Continuum Using a Nationally Representative Real-World Database in the United States.
    Tahami Monfared AA; Fu S; Hummel N; Qi L; Chandak A; Zhang R; Zhang Q
    Neurol Ther; 2023 Aug; 12(4):1235-1255. PubMed ID: 37256433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular risk factors as potential markers for mild cognitive impairment and Alzheimer's disease.
    Ciobica A; Padurariu M; Bild W; Stefanescu C
    Psychiatr Danub; 2011 Dec; 23(4):340-6. PubMed ID: 22075734
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corpus callosum atrophy associated with the degree of cognitive decline in patients with Alzheimer's dementia or mild cognitive impairment: a meta-analysis of the region of interest structural imaging studies.
    Wang XD; Ren M; Zhu MW; Gao WP; Zhang J; Shen H; Lin ZG; Feng HL; Zhao CJ; Gao K
    J Psychiatr Res; 2015 Apr; 63():10-9. PubMed ID: 25748753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Motivational reserve: motivation-related occupational abilities and risk of mild cognitive impairment and Alzheimer disease.
    Forstmeier S; Maercker A; Maier W; van den Bussche H; Riedel-Heller S; Kaduszkiewicz H; Pentzek M; Weyerer S; Bickel H; Tebarth F; Luppa M; Wollny A; Wiese B; Wagner M;
    Psychol Aging; 2012 Jun; 27(2):353-63. PubMed ID: 21875213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Varying strength of cognitive markers and biomarkers to predict conversion and cognitive decline in an early-stage-enriched mild cognitive impairment sample.
    Egli SC; Hirni DI; Taylor KI; Berres M; Regeniter A; Gass A; Monsch AU; Sollberger M
    J Alzheimers Dis; 2015; 44(2):625-33. PubMed ID: 25322924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory impairment, in mild cognitive impairment without significant cerebrovascular disease, predicts progression to Alzheimer's disease.
    Lee YM; Park JM; Lee BD; Moon E; Chung YI; Kang CJ
    Dement Geriatr Cogn Disord; 2012; 33(4):240-4. PubMed ID: 22738930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence and associated behavioral symptoms of depression in mild cognitive impairment and dementia due to Alzheimer's disease.
    Van der Mussele S; Bekelaar K; Le Bastard N; Vermeiren Y; Saerens J; Somers N; Mariën P; Goeman J; De Deyn PP; Engelborghs S
    Int J Geriatr Psychiatry; 2013 Sep; 28(9):947-58. PubMed ID: 23255479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.